Drotaverine is a benzylisoquinoline derivative and an antispasmodic agent that functions as a phosphodiesterase IV inhibitor to relax smooth muscle, particularly in the gastrointestinal tract, uterus,… Read more




















Drotaverine is a benzylisoquinoline derivative and an antispasmodic agent that functions as a phosphodiesterase IV inhibitor to relax smooth muscle, particularly in the gastrointestinal tract, uterus, and biliary system. It is commonly used for conditions involving smooth muscle spasms, including dysmenorrhea and abdominal pain. This category offers high-quality reference standards for Drotaverine, including the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, and metabolites such as drotaveraldine. Laboratories utilize these compounds for comprehensive impurity profiling and to support rigorous quality control processes during pharmaceutical development. Additionally, stable isotope labelled compounds are available to serve as internal standards for quantitative analysis in complex biological matrices, ensuring accuracy in method validation and routine analytical testing. These analytical tools enable precise identification and quantification of impurities in accordance with international regulatory requirements for drug safety and consistency.